Latest Manufacturing News

Bioxyne Limited has delivered a record-breaking second quarter in FY2026, posting $17.2 million in revenue and expanding its footprint into key international markets. The company’s growth is underpinned by new contracts, innovative psychedelics products, and strategic government funding.

Janus Electric has inked a strategic partnership with a Canadian consortium to deploy swappable battery electric trucks powered by innovative negative-carbon energy, aiming to revolutionise long-haul freight electrification.

Alpha HPA Limited reports strong progress on its HPA First Project Stage 2 construction and secures binding supply contracts for 2026 in the booming semiconductor sector, while launching a $225 million equity raise to fund expansion.

Mesoblast Limited reported a 60% jump in Ryoncil sales to US$35 million for the December quarter, alongside securing a US$125 million credit facility that enhances its financial flexibility and supports ongoing clinical development.

Comet Ridge is set to consolidate 100% ownership of the Mahalo Gas Project, securing key environmental approvals and advancing engineering design and funding efforts to boost east coast gas supply.

Zimi Limited has reported a striking 300% year-on-year revenue surge alongside the industrialisation of its next-generation Senoa Matter smart home range, signalling a pivotal moment in its growth and market positioning.

SRJ Technologies has completed the first phase of its growth strategy and is now advancing into market penetration with a significant $23.8 million joint venture in the Middle East and a key board appointment.

Ark Mines has made significant strides in advancing its Sandy Mitchell Rare Earths Project, initiating a full-scale processing trial and securing critical environmental approvals, setting the stage for production by late 2027.

Imagion Biosystems has completed manufacturing its MagSense® HER2 imaging agent and is preparing for a key FDA submission, while appointing a new president to lead its US operations.

Alpha HPA Limited has raised A$225 million in a fully underwritten placement to fund the commercialisation of Stage 2 of its High Purity Alumina project, with strong backing from the National Reconstruction Fund Corporation. This capital injection positions the company to become the world’s largest single-site HPA manufacturer, supporting critical semiconductor supply chains.

Mayne Pharma delivered a robust FY25 performance with a 105% surge in underlying EBITDA and launched key dermatology products as it outlines a strategic growth path for FY26.

BrainChip Holdings has bolstered its financial position with a A$35 million capital raise and commenced volume production of its AKD1500 neuromorphic AI chip, while deepening its strategic partnership with Parsons’ defence arm.